Managing drug withdrawal in the newborn infant

Seminars in Fetal and Neonatal Medicine

Volumn 12, Issue 2, 2007, Pages 127-133

  Kuschel, Carl ^a  

^a AUCKLAND DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

Neonatal abstinence syndrome; Opioids; Substance use

Indexed keywords

ALCOHOL; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CAFFEINE; CHLORPROMAZINE; CLONIDINE; COCAINE; DIAMORPHINE; DIAZEPAM; ILLICIT DRUG; METHADONE; MORPHINE; NALOXONE; OPIATE; PAREGORIC; PHENOBARBITAL; SEROTONIN UPTAKE INHIBITOR; SHORT ACTING DRUG; SOLVENT; VALPROIC ACID;

ARTICLE; BREAST FEEDING; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONVULSION; DEPRESSION; DISEASE SEVERITY; DRUG DETERMINATION; DRUG DETOXIFICATION; DRUG USE; FINNEGAN SCORING SYSTEM; HAIR ANALYSIS; HOSPITAL CARE; HUMAN; INFANT FEEDING; MECONIUM; MONOTHERAPY; NEWBORN; NEWBORN ASSESSMENT; NEWBORN CARE; NICU NETWORK NEUROBEHAVIOURAL SCALE; OUTPATIENT CARE; PARENT; PARENTAL BEHAVIOR; POLYPHARMACY; PREMATURITY; PRENATAL DRUG EXPOSURE; RATING SCALE; SCORING SYSTEM; SOCIAL ASPECT; SUBSTANCE ABUSE; SYMPTOMATOLOGY; TERM BIRTH; TOXICOLOGY; URINALYSIS; VIRUS TRANSMISSION; WITHDRAWAL SYNDROME;

FEMALE; HUMANS; INFANT, NEWBORN; MECONIUM; NEONATAL ABSTINENCE SYNDROME; PREGNANCY;

EID: 33847685187     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2007.01.004     Document Type: Article

References (57)

1. Ebrahim S.H., and Gfroerer J. Pregnancy-related substance use in the United States during 1996-1998. Obstet Gynecol 101 2 (2003) 374-379
2. Arria A.M., Derauf C., Lagasse L.L., Grant P., Shah R., Smith L., et al. Methamphetamine and other substance use during pregnancy: preliminary estimates from the Infant Development, Environment, and Lifestyle (IDEAL) study. Matern Child Health J 10 3 (2006) 293-302
3. Brown J.V., Bakeman R., Coles C.D., Sexson W.R., and Demi A.S. Maternal drug use during pregnancy: are preterm and full-term infants affected differently?. Dev Psychol 34 3 (1998) 540-554
4. Abdel-Latif M.E., Pinner J., Clews S., Cooke F., Lui K., and Oei J. Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics 117 6 (2006) e1163-e1169
5. Martinez A., Kastner B., and Taeusch H.W. Hyperphagia in neonates withdrawing from methadone. Arch Dis Child Fetal Neonatal Ed 80 3 (1999) F178-F182
6. McCarthy J., Leamon M.H., Parr M.S., and Anania B. High-dose methadone maintenance in pregnancy: maternal and neonatal outcomes. Am J Obstet Gynecol 193 3 Pt 1 (2005) 606-610
7. Rosen T.S., and Pippenger C.E. Pharmacologic observations on the neonatal withdrawal syndrome. J Pediatr 88 6 (1976) 1044-1048
8. Mack G., Thomas D., Giles W., and Buchanan N. Methadone levels and neonatal withdrawal. J Paediatr Child Health 27 2 (1991) 96-100
9. Berghella V., Lim P.J., Hill M.K., Cherpes J., Chennat J., and Kaltenbach K. Maternal methadone dose and neonatal withdrawal. Am J Obstet Gynecol 189 2 (2003) 312-317
10. Dashe J.S., Sheffield J.S., Olscher D.A., Todd S.J., Jackson G.L., and Wendel G.D. Relationship between maternal methadone dosage and neonatal withdrawal. Obstet Gynecol 100 6 (2002) 1244-1249
11. Harper R.G., Solish G., Feingold E., Gersten-Woolf N.B., and Sokal M.M. Maternal ingested methadone, body fluid methadone, and the neonatal withdrawal syndrome. Am J Obstet Gynecol 129 4 (1977) 417-424
12. Ostrea Jr. E.M., Chavez C.J., and Strauss M.E. A study of factors that influence the severity of neonatal narcotic withdrawal. Addict Dis 2 1-2 (1975) 187-199
13. Arlettaz R., Kashiwagi M., Das-Kundu S., Fauchere J.C., Lang A., and Bucher H.U. Methadone maintenance program in pregnancy in a Swiss perinatal center (II): neonatal outcome and social resources. Acta Obstet Gynecol Scand 84 2 (2005) 145-150
14. Kuschel C.A., Austerberry L., Cornwell M., Couch R., and Rowley R.S.H. Can methadone concentrations predict the severity of withdrawal in infants at risk of neonatal abstinence syndrome?. Arch Dis Child Fetal Neonatal Ed 89 (2004) F390-F393
15. Kandall S.R., Albin S., Gartner L.M., Lee K.S., Eidelman A., and Lowinson J. The narcotic-dependent mother: fetal and neonatal consequences. Early Hum Dev 1 2 (1977) 159-169
16. Wilson G.S., Desmond M.M., and Wait R.B. Follow-up of methadone-treated and untreated narcotic-dependent women and their infants: health, developmental, and social implications. J Pediatr 98 5 (1981) 716-722
17. Sharpe C., and Kuschel C. Outcomes of infants born to mothers receiving methadone for pain management in pregnancy. Arch Dis Child Fetal Neonatal Ed 89 1 (2004) F33-F36
18. Sarkar S., and Donn S.M. Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. J Perinatol 26 1 (2006) 15-17
19. Finnegan L.P., Connaughton Jr. J.F., Kron R.E., and Emich J.P. Neonatal abstinence syndrome: assessment and management. Addict Dis 2 1-2 (1975) 141-158
20. Coyle M.G., Ferguson A., Lagasse L., Oh W., and Lester B. Diluted tincture of opium (DTO) and phenobarbital versus DTO alone for neonatal opiate withdrawal in term infants. J Pediatr 140 (2002) 561-564
21. O'Brien C., Hunt R., and Jeffery H.E. Measurement of movement is an objective method to assist in assessment of opiate withdrawal in newborns. Arch Dis Child Fetal Neonatal Ed 89 (2004) F305-F309
22. Theis J.G., Selby P., Ikizler Y., and Koren G. Current management of the neonatal abstinence syndrome: a critical analysis of the evidence. Biol Neonate 71 6 (1997) 345-356
23. Lipsitz P.J. A proposed narcotic withdrawal score for use with newborn infants. A pragmatic evaluation of its efficacy. Clin Pediatr 14 6 (1975) 592-594
24. Boukydis C.F.Z., Bigsby R., and Lester B.M. Clinical use of the Neonatal Intensive Care Unit Network Behavioural Scale. Pediatrics 113 3 Pt 2 (2004) 679-689
25. Lester B.M., and Tronick E.Z. History and description of the Neonatal Intensive Care Unit Network Neurobehavioral Scale. Pediatrics 113 3 Pt 2 (2004) 634-640
26. Koren G., Matsui D., Einarson A., Knoppert D., and Steiner M. Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?. CMAJ 172 11 (2005) 1457-1459
27. Sanz E.J., De-las-Cuevas C., Kiuru A., Bate A., and Edwards R. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 365 9458 (2005) 482-487
28. Swortfiguer D., Cissoko H., Giraudeau B., Jonville-Bera A.P., Bensouda L., and Autret-Leca E. Retentissement néonatal de l'exposition aux benzodiazépines en fin de grossesse [Neonatal consequences of benzodiazepines used during the last month of pregnancy]. Arch Pediatr 12 9 (2005) 1327-1331
29. Bauer C.R., Langer J.C., Shankaran S., Bada H.S., Lester B., Wright L.L., et al. Acute neonatal effects of cocaine exposure during pregnancy. Arch Pediatr Adolesc Med 159 9 (2005) 824-834
30. Desmond M.M., Schwanecke R.P., Wilson G.S., Yasunaga S., and Burgdorff I. Maternal barbiturate utilization and neonatal withdrawal symptomatology. J Pediatr 80 2 (1972) 190-197
31. Coles C.D., Smith I.E., Fernhoff P.M., and Falek A. Neonatal ethanol withdrawal: characteristics in clinically normal, nondysmorphic neonates. J Pediatr 105 3 (1984) 445-451
32. McKim E.M. Caffeine and its effects on pregnancy and the neonate. J Nurse Midwifery 36 4 (1991) 226-231
33. Ebbesen F., Joergensen A., Hoseth E., Kaad P., Moeller M., Holsteen V., et al. Neonatal hypoglycaemia and withdrawal symptoms after exposure in utero to valproate. Arch Dis Child Fetal Neonatal Ed 83 2 (2000) F124-F129
34. Tenenbein M., Casiro O.G., Seshia M.M., and Debooy V.D. Neonatal withdrawal from maternal volatile substance abuse. Arch Dis Child Fetal Neonatal Ed 74 3 (1996) F204-F207
35. Chasnoff I.J. Drug use and women: establishing a standard of care. Ann N Y Acad Sci 562 (1989) 208-210
36. Ostrea Jr. E.M., Knapp D.K., Tannenbaum L., Ostrea A.R., Romero A., Salari V., et al. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis. J Pediatr 138 3 (2001) 344-348
37. Lester B.M., ElSohly M., Wright L.L., Smeriglio V.L., Verter J., Bauer C.R., et al. The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report. Pediatrics 107 2 (2001) 309-317
38. Ostrea Jr. E.M. Testing for exposure to illicit drugs and other agents in the neonate: a review of laboratory methods and the role of meconium analysis. Curr Probl Pediatr 29 2 (1999) 41-56
39. Ostrea E.M.J., Matias O., Keane C., Mac E., Utarnachitt R., Ostrea A., et al. Spectrum of gestational exposure to illicit drugs and other xenobiotic agents in newborn infants by meconium analysis. J Pediatr 133 4 (1998) 153-155
40. Montgomery D., Plate C., Alder S.C., Jones M., Jones J., and Christensen R.D. Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium. J Perinatol 26 1 (2006) 11-14
41. Doberczak T.M., Kandall S.R., and Wilets I. Neonatal opiate abstinence syndrome in term and preterm infants. J Pediatr 118 6 (1991) 933-937
42. Strauss M.E., Andresko M., Stryker J.C., Wardell J.N., and Dunkel L.D. Methadone maintenance during pregnancy: pregnancy, birth, and neonate characteristics. Am J Obstet Gynecol 120 7 (1974) 895-900
43. D'Apolito K. Comparison of a rocking bed and standard bed for decreasing withdrawal symptoms in drug-exposed infants. MCN Am J Matern Child Nurs 24 3 (1999) 138-144
44. American Academy of Pediatrics, Committee on Drugs. Neonatal drug withdrawal. Pediatrics 101 6 (1998) 1079-1088
45. Osborn D.A., Jeffery H.E., and Cole M. Opiate treatment for opiate withdrawal in newborn infants. Cochrane Database Syst Rev 3 (2005) CD002059 10.1002/14651858 [CD002059.pub2]
46. Osborn D.A., Jeffery H.E., and Cole M.J. Sedatives for opiate withdrawal in newborn infants. Cochrane Database Syst Rev 3 (2005) CD002053 10.1002/14651858 [CD002053.pub2]
47. Johnson K., Gerada C., and Greenough A. Treatment of neonatal abstinence syndrome. Arch Dis Child Fetal Neonatal Ed 88 1 (2003) F2-F5
48. Jackson L., Ting A., McKay S., Galea P., and Skeoch C. A randomised controlled trial of morphine versus phenobarbitone for neonatal abstinence syndrome. Arch Dis Child Fetal Neonatal Ed 89 4 (2004) F300-F304
49. Lainwala S., Brown E.R., Weinschenk N.P., Blackwell M.T., and Hagadorn J.I. A retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations. Adv Neonatal Care 5 5 (2005) 265-272
50. Coyle M.G., Ferguson A., LaGasse L., Lui J., and Lester B. Neurobehavioral effects of treatment for opiate withdrawal. Arch Dis Child Fetal Neonatal Ed 90 (2005) 73-74
51. Oei J., Feller J.M., and Lui K. Coordinated outpatient care of the narcotic-dependent infant. J Paediatr Child Health 37 3 (2001) 266-270
52. Shephard R., Greenough A., Johnson K., and Gerada C. Hyperphagia, weight gain and neonatal drug withdrawal. Acta Paediatr 91 9 (2002) 951-953
53. American Academy of Pediatrics, Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics 108 3 (2001) 776-789
54. Malpas T.J., and Darlow B.A. Neonatal abstinence syndrome following abrupt cessation of breastfeeding. N Z Med J 112 1080 (1999) 12-13
55. Slowik M.K., and Jhaveri R. Hepatitis B and C viruses in infants and young children. Semin Pediatr Infect Dis 16 4 (2005) 296-305
56. Kashiwagi M., Arlettaz R., Lauper U., Zimmermann R., and Hebisch G. Methadone maintenance program in a Swiss perinatal center: (I). Management and outcome of 89 pregnancies. Acta Obstet Gynecol Scand 84 2 (2005) 140-144
57. Hunt C.E., and Hauck F.R. Sudden infant death syndrome. CMAJ 174 13 (2006) 1861-1869